Renaissance Group LLC lowered its stake in shares of Afya Limited (NASDAQ:AFYA – Free Report) by 12.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 102,260 shares of the company’s stock after selling 14,271 shares during the quarter. Renaissance Group LLC owned approximately 0.11% of Afya worth $1,826,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in AFYA. Cerity Partners LLC bought a new position in shares of Afya during the first quarter worth about $476,000. Goldman Sachs Group Inc. lifted its position in Afya by 167.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after purchasing an additional 28,226 shares during the last quarter. Doma Perpetual Capital Management LLC boosted its stake in Afya by 4.4% during the 1st quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company’s stock valued at $10,619,000 after purchasing an additional 25,111 shares during the period. Carrera Capital Advisors acquired a new position in shares of Afya during the second quarter worth approximately $1,750,000. Finally, Perpetual Ltd grew its holdings in Afya by 1.8% in the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock worth $2,700,000 after buying an additional 2,730 shares in the last quarter. 88.02% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
AFYA has been the subject of several research analyst reports. Wall Street Zen raised shares of Afya from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 15th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a report on Wednesday, October 8th. Morgan Stanley set a $17.50 price objective on shares of Afya and gave the company an “overweight” rating in a research note on Wednesday, August 6th. Citigroup raised Afya from a “sell” rating to a “neutral” rating and decreased their price target for the company from $16.00 to $14.00 in a research note on Tuesday, July 29th. Finally, Zacks Research raised Afya to a “hold” rating in a research note on Friday, August 8th. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Afya has an average rating of “Hold” and an average price target of $18.20.
Afya Stock Up 0.3%
AFYA stock opened at $14.82 on Thursday. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.98 and a quick ratio of 0.98. The firm has a market capitalization of $1.39 billion, a P/E ratio of 10.66, a P/E/G ratio of 0.45 and a beta of 0.57. Afya Limited has a 52-week low of $13.47 and a 52-week high of $19.90. The company’s 50 day simple moving average is $15.01 and its 200-day simple moving average is $16.06.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also
- Five stocks we like better than Afya
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Applied Materials: Up 40% in 2025 With Room to Run Long-Term
- How to Calculate Return on Investment (ROI)
- onsemi Places a $6 Billion Bet on Its Own Stock
- What Are Dividend Achievers? An Introduction
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
